Hepatic Proliferation and Angiogenesis Markers Are Increased after Portal Deprivation in Rats: A Study of Molecular, Histological and Radiological Changes-Reference-Cited by-同舟云学术

Hepatic Proliferation and Angiogenesis Markers Are Increased after Portal Deprivation in Rats: A Study of Molecular, Histological and Radiological Changes

Published:2015-05-28 Issue:5 Volume:10 Page:e0125493
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Guérin Florent,Wagner Mathilde,Liné Antoine,Zappa Magaly,Fasseu Magali,Paradis Valérie,Vilgrain Valérie,Van Beers Bernard E.,Legagneux Josette,Moreau Richard,Lettéron Philippe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Complications of Congenital Portosystemic Shunts in Children: Therapeutic Options and Outcomes;S Franchi-Abella;J Pediatr Gastroenterol Nutr,2010

2. Liver nodules after portal systemic shunt surgery for extrahepatic portal vein obstruction in children;F Guérin;J Pediatr Surg,2009

3. Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): A Histopathologic Evaluation;M Lisovsky;Am J Surg Pathol,2011

4. Liver transplantation for hepatoblastoma in a child with congenital absence of the portal vein;JW Barton 3rd;Pediatr Radiol,1989

5. Obliterative portal venopathy: Portal hypertension is not always present at diagnosis;D Cazals-Hatem;J Hepatol,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Hepatotropic Viral, Bacterial and Parasitic Infections of the Liver;MacSween's Pathology of the Liver;2024

2. Hepatosplenic Schistosomiasis-Associated Chronic Portal Vein Thrombosis: Risk Factor for Hepatocellular Carcinoma;2023-04-25

3. HEPATOSPLENIC SCHISTOSOMIASIS-ASSOCIATED CHRONIC PORTAL VEIN THROMBOSIS: RISK FACTOR FOR HEPATOCELLULAR CARCINOMA?;ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo);2023

4. Hepatic lymphatic vascular system in health and disease;Journal of Hepatology;2022-07

5. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases;Current Drug Targets;2019-07-12